Lv2
198 积分 2024-05-18 加入
Therapy-driven clonal dynamics in chronic lymphocytic leukemia
16小时前
已完结
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β
1个月前
已完结
How I treat secondary CNS involvement by aggressive lymphomas
1个月前
已完结
Management of secondary central nervous system lymphoma
1个月前
已完结
Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia
1个月前
已完结
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies
1个月前
已完结
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
1个月前
已完结
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia
1个月前
已完结
TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma
1个月前
已完结
The role of phosphatidylcholine metabolism in tumors
1个月前
已完结
皖公网安备34019202002308
